Thor Medical ASA (TRMED) NOK0.2
Sell:2.38 NOKBuy:2.39 NOK
0.02 NOK
(0.63%)
- This stock can be held in a
Stocks and Shares ISA0.02 NOK
(0.63%)0.02 NOK
(0.63%)Company Information
About this company
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells
Key people
Key facts
- EPICTRMED
- LocationNorway
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINNO0010597883
- Market capNOK 751.44m
- Employees9
- Shares in issue280.49m
- ExchangeOslo Stock Exchange
- IndexOSL All-share Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.